{"id":"W4409822191","doi":"10.1158/1538-7445.am2025-ct094","title":"Abstract CT094: Durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Outcomes by PD-L1 expression in ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Chemoradiotherapy; Placebo; Cancer; Pathology; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007985237,0.0008650404,0.001699864,0.000313929,0.000248188,0.0005713712,0.000752061,0.0007600721,0.004773924],"category_scores_gemma":[0.0008300245,0.0002739645,0.0009046428,0.0003222702,0.0007438712,0.0005348274,0.0002600773,0.002210031,0.0006479927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006775738,"about_ca_system_score_gemma":0.00106529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000923573,"about_ca_topic_score_gemma":0.002358037,"domain_scores_codex":[0.9996208,0.0001840024,0.00002776942,0.00006418949,0.00003002482,0.00007314204],"domain_scores_gemma":[0.9994296,0.0001282263,0.0001288247,0.00005302031,0.00003021409,0.0002300195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9534936,0.006961551,0.0009801888,0.0002370258,0.0004248796,0.00003471127,0.00002385646,0.0004536096,0.01061309,0.00007719725,0.0009128404,0.02578755],"study_design_scores_gemma":[0.5546328,0.4244015,0.01058562,0.00004517866,0.0008592913,0.0001243367,0.00003118259,0.001372757,0.006567124,0.0002071623,0.001148227,0.00002463826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956375,0.001067157,0.0002063904,0.0002150663,0.0001546975,0.0006167816,0.000825192,0.00006789488,0.001209398],"genre_scores_gemma":[0.9962399,0.0004261888,0.0003435375,0.0001688614,0.00009175305,0.000506065,0.0006987194,0.000008480264,0.001516449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004773924,"threshold_uncertainty_score":0.01597035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04740485122507896,"score_gpt":0.4421369264632889,"score_spread":0.3947320752382099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}